Sahpra News Updates

Pretoria, 02 July 2025 – The South African Health Products Regulatory Authority (SAHPRA) welcomes its newly appointed Board Members. The SAHPRA Board is appointed by the Minister of the National Department of Health, Dr Aaron Motsoaledi. The appointment is in accordance with section 2C(2) of... The post  SAHPRA welcomes new… Read more »

Pretoria, 18 June 2025 Meeting highlights: EF: What are you most proud of in your five-year tenure leading SAHPRA, and what do you consider the key highlights of this period?  BS: We did a lot, but I would say it falls into three main areas, considering where SAHPRA... The post Executive Forecast 2025:… Read more »

A Thought Leadership Article by SAHPRA’s CEO, Dr Boitumelo Semete-Makokotlela Introduction Pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problems, which play a crucial role in ensuring public safety. The South African... The post The Impact of… Read more »

Pretoria, 11 June 2025—The South African Health Products Regulatory Authority (SAHPRA) is warning the public to be vigilant and cautious when engaging with service providers who claim to be licensed by SAHPRA. SAHPRA has learned that individuals and companies are operating unethically by presenting falsified... The post  SAHPRA alerts the… Read more »

04 June 2025 – The South African Health Products Regulatory Authority (SAHPRA) recently visited the Egyptian Drug Authority (EDA) at their Cairo Offices for an intensive training programme to capacitate the Regulator on how to achieve recognition for the World Health Organization (WHO) Global Benchmarking... The post  SAHPRA undergoes training… Read more »

The South African Health Products Regulatory Authority (SAHPRA) would like to inform healthcare professionals about the risk of a drug-drug interaction (DDI) associated with concomitant use of warfarin and tramadol. Taking these two medicines simultaneously can lead to an increase in the International Normalised Ratio... The post Warfarin and Tramadol… Read more »

Pretoria, 22 May 2025 –The South African Health Products Regulatory Authority (SAHPRA), having applied Reliance on the World Health Organization (WHO) PQ assessment under Emergency Use Listing, has listed the first mpox (monkeypox) in vitro diagnostic (IVD). This serves as an important step in improving global access to mpox testing by using a reliance process. The emergency use approval of the Alinity m... The post SAHPRA Approves First… Read more »

Pretoria, 04 April 2025 –The South African Health Products Regulatory Authority (SAHPRA) has joined the Medical Device Single Audit Programme (MDSAP), an international audit programme of medicines and medical device regulators aimed at improving efficiencies in the regulation of medical device manufacturers by engaging in work... The post SAHPRA joins the Medical… Read more »

Pretoria, 24 March 2025 –The South African Health Products Regulatory Authority (SAHPRA), in partnership with Pharmacometrics Africa and the Department of Pharmacy and Pharmacology at the University of the Witwatersrand, proudly announces the graduation of the fourth cohort from the Clinical Assessors Short Course —... The post SAHPRA Strengthens Regulatory… Read more »

The South African Health Products Regulatory Authority (SAHPRA) has published four (4) Expression of Interests (EOIs) since 2023, and these have all been closed. Updates on EOIs: Download PDF The post Update: Feedback on SAHPRA’s EOIs and latest appointments appeared first on SAHPRA. Read more »